volume 2, issue 8, PS449 2007
DOI: 10.1097/01.jto.0000283376.48091.90
View full text
|
|
Share

Abstract: 2 cycles of chemotherapy. Common non-hematologic toxicities of all grades during consolidation chemotherapy were anorexia(45%), alopecia(41%), asthenia(35%), and esophagitis(41%). Hematologic toxicities were mild. Although Grade 3-4 neutropenia occurred in 5 cycles out of 65 cycles, there was no treatment-related mortality Conclusions: These results suggest that CCRT with weekly docetaxel and cisplatin is feasible and consolidation chemotherapy with same agents after CCRT is also well tolerated. Further data w…

Expand abstract

Search citation statements

Order By: Relevance

Citation Types

0
0
0

Paper Sections

0
0
0
0
0

Publication Types

0
0
0
0

Relationship

0
0

Authors

Journals